Grace Therapeutics, Inc. (GRCE)

NASDAQ·Healthcare·Biotechnology

$2.12

-1.85%

Mkt Cap $55.53M

No analyst coverage available

We don't have analyst ratings or price target data for Grace Therapeutics, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.